International Journal of Clinical Case Reports, 2025, Vol.15, No.6, 271-282 http://medscipublisher.com/index.php/ijccr 281 Muraro A., Worm M., Alviani C., Cardona V., DunnGalvin A., Garvey L., Riggioni C., De Silva D., Angier E., Arasi S., Bellou A., Beyer K., Bijlhout D., Biló M., Bindslev‐Jensen C., Brockow K., Fernández-Rivas M., Halken S., Jensen B., Khaleva E., Michaelis L., Elberink H., Regent L., Sanchez A., Vlieg‐Boerstra B., and Roberts G., 2021, EAACI guidelines: anaphylaxis (2021 update), Allergy, 77: 357-377. https://doi.org/10.1111/all.15032 Nguyen S., Rupprecht C., Haque A., Pattanaik D., Yusin J., and Krishnaswamy G., 2021, Mechanisms governing anaphylaxis: inflammatory cells mediators endothelial gap junctions and beyond, International Journal of Molecular Sciences, 22(15): 7785. https://doi.org/10.3390/ijms22157785 Nicola S., Badiu I., Rashidy N., Saracco E., Montabone E., Lo Sardo L., Boem M., Marmora V., Corradi F., Ricotti A., Borrelli R., Rolla G., Negrini S., and Brussino L., 2025, Evaluating vaccination dosing strategies for SARS-CoV-2 in patients at high-risk for allergic reactions: insights from vaccination campaign, The World Allergy Organization Journal, 18(8): 101095. https://doi.org/10.1016/j.waojou.2025.101095 Orchard A., Vally M., Khan R., and Irhuma M., 2022, A guide for the management of post vaccination allergy and anaphylaxis in a pharmacy clinic, Health SA Gesondheid, 27: 1987. https://doi.org/10.4102/hsag.v27i0.1987 Ota M., Hoehn K., Fernandes-Braga W., Ota T., Aranda C., Friedman S., Miranda-Waldetario M., Redes J., Suprun M., Grishina G., Sampson H., Malbari A., Kleinstein S., Sicherer S., and De Lafaille M., 2024, CD23+IgG1+memory B cells are poised to switch to pathogenic IgE production in food allergy, Science Translational Medicine, 16(733): eadi0673. https://doi.org/10.1126/scitranslmed.adi0673 Paoletti G., Racca F., Piona A., Melone G., Merigo M., Puggioni F., Ferri S., Azzolini E., Lagioia M., Lamacchia D., Cataldo G., Cecconi M., Canonica G., and Heffler E., 2021, Successful SARS-CoV-2 vaccine allergy risk-management: the experience of a large Italian university hospital, The World Allergy Organization Journal, 14(5): 100541. https://doi.org/10.1016/j.waojou.2021.100541 Paul P., Janjua E., AlSubaie M., Ramadorai V., Mushannen B., Vattoth A., Khan W., Bshesh K., Nauman A., Mohammed I., Bouhali I., Khalid M., and Zakaria D., 2022, Anaphylaxis and related events following COVID‐19 vaccination: a systematic review, Journal of Clinical Pharmacology, 62(11): 1335-1349. https://doi.org/10.1002/jcph.2120 Pennisi F., D’Amelio A., Cuciniello R., Borlini S., Mirzaian L., Ricciardi G., Minerva M., Gianfredi V., and Signorelli C., 2025, Post-vaccination anaphylaxis in adults: a systematic review and meta-analysis, Vaccines, 13(1): 37. https://doi.org/10.3390/vaccines13010037 Pércio J., Kobayashi C., Silva R., Marinho A., Capovilla L., Andrade P., Da Nóbrega M., Cabral C., De Moraes M., Werneck G., and Fernandes E., 2024, Safety signal detected: anaphylaxis after attenuated dengue vaccine (TAK-003)-Brazil march 1 2023-march 11 2024, Vaccine, 42(26): 126407. https://doi.org/10.1016/j.vaccine.2024.126407 Pienkowski S., and Pienkowski M., 2025, Resolution of patient's anaphylaxis to the moderna COVID-19 vaccine by desensitization, HCA Healthcare Journal of Medicine, 6(2): 167-170. https://doi.org/10.36518/2689-0216.1792 Pignatti P., Ramirez G., Russo M., Marraccini P., Nannipieri S., Asperti C., Torre F., Tiri A., Gatti B., Gurrado A., Meriggi A., Benanti G., Cilona M., Pigatto P., Burastero S., Dagna L., and Yacoub M., 2023, Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: basophil reactivity to excipients, Vaccine, 41(32): 4693-4699. https://doi.org/10.1016/j.vaccine.2023.06.039 Restivo V., Candore G., Barrale M., Caravello E., Graziano G., Onida R., Raineri M., Tiralongo S., and Brusca I., 2021, Allergy to polyethilenglicole of anti-SARS CoV2 vaccine recipient: a case report of young adult recipient and the management of future exposure to SARS-CoV2, Vaccines, 9(5): 412. https://doi.org/10.3390/vaccines9050412 Risma K., Edwards K., Hummell D., Little F., Norton A., Stallings A., Wood R., and Milner J., 2021, Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines, The Journal of Allergy and Clinical Immunology, 147: 2075-2082. https://doi.org/10.1016/j.jaci.2021.04.002 Sokolowska M., Eiwegger T., Ollert M., Torres M., Barber D., Del Giacco S., Jutel M., Nadeau K., Palomares Ó., Rabin R., Riggioni C., Vieths S., Agache I., and Shamji M., 2021, EAACI statement on the diagnosis management and prevention of severe allergic reactions to COVID‐19 vaccines, Allergy, 76: 1629-1639. https://doi.org/10.1111/all.14739 Tanno L., Bérard F., Beaudoin É., Didier A., and Demoly P., 2021, SARS-CoV-2 vaccination and anaphylaxis: recommendations of the french allergy community and the montpellier world health organization collaborating center, Vaccines, 9(6): 560. https://doi.org/10.3390/vaccines9060560 Toledo-Salinas C., Scheffler-Mendoza S., Castano-Jaramillo L., Ortega-Martell J., Del Río-Navarro B., Santibáñez-Copado A., Díaz-Ortega J., Baptista-Rosas R., Sánchez-Novoa P., García‐Grimshaw M., Valdés-Ferrer S., Reyes-Terán G., and Mendoza-Hernández D., 2022, Anaphylaxis to SARS-CoV-2 vaccines in the setting of a nationwide passive epidemiological surveillance program, Journal of Clinical Immunology, 42: 1593-1599. https://doi.org/10.1007/s10875-022-01350-1 Wentrys Ł., and Stopyra L., 2022, COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction-own observations, Przeglad Epidemiologiczny, 75(3): 315-325. https://doi.org/10.32394/pe.75.28
RkJQdWJsaXNoZXIy MjQ4ODYzNA==